Pub Date : 2025-04-01Epub Date: 2025-04-04DOI: 10.24171/j.phrp.2025.0037
Chaeshin Chu
Global health security threats in the post-coronavirus disease 2019 era include dense urban populations, increased human-animal proximity, migration driven by political or economic instability, climate change, humanitarian crises, antimicrobial resistance (AMR), and the misuse of biological research-including the accidental or intentional release of high-risk pathogens. The foundational preparation for these threats is to establish a robust, resilient public health system based on universal health coverage. The World Health Organization's International Health Regulations must continue to promote global solidarity by maintaining core capacities such as surveillance, national laboratories, and epidemiological investigations of emerging infectious diseases, with timely reporting and information sharing within the global health security community. A One Health approach is essential for addressing AMR. Infection prevention and control must be enhanced to reduce healthcare-associated infections in medical facilities. Additionally, regulations concerning biosafety and biosecurity should address dual-use research of concern as well as the accidental or intentional release of highrisk pathogens from laboratories. Global health security is a collective responsibility because these threats know no borders and require coordinated action.
{"title":"Global health security in the post-COVID-19 era: threats, preparation, and response.","authors":"Chaeshin Chu","doi":"10.24171/j.phrp.2025.0037","DOIUrl":"10.24171/j.phrp.2025.0037","url":null,"abstract":"<p><p>Global health security threats in the post-coronavirus disease 2019 era include dense urban populations, increased human-animal proximity, migration driven by political or economic instability, climate change, humanitarian crises, antimicrobial resistance (AMR), and the misuse of biological research-including the accidental or intentional release of high-risk pathogens. The foundational preparation for these threats is to establish a robust, resilient public health system based on universal health coverage. The World Health Organization's International Health Regulations must continue to promote global solidarity by maintaining core capacities such as surveillance, national laboratories, and epidemiological investigations of emerging infectious diseases, with timely reporting and information sharing within the global health security community. A One Health approach is essential for addressing AMR. Infection prevention and control must be enhanced to reduce healthcare-associated infections in medical facilities. Additionally, regulations concerning biosafety and biosecurity should address dual-use research of concern as well as the accidental or intentional release of highrisk pathogens from laboratories. Global health security is a collective responsibility because these threats know no borders and require coordinated action.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"116-125"},"PeriodicalIF":2.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12066230/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143796607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-04-29DOI: 10.24171/j.phrp.2025.0132
Jong-Koo Lee
{"title":"The Republic of Korea's post-COVID-19 pandemic preparedness: it is time to assess the progress of pandemic preparedness.","authors":"Jong-Koo Lee","doi":"10.24171/j.phrp.2025.0132","DOIUrl":"https://doi.org/10.24171/j.phrp.2025.0132","url":null,"abstract":"","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"16 2","pages":"91-93"},"PeriodicalIF":2.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12066234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144052076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-02-21DOI: 10.24171/j.phrp.2024.0254
Ji-Seon Seong, Jong-Yeon Kim
Background: This study aimed to investigate the combined effects of individual, household, and community-level factors on coronavirus disease 2019 (COVID-19) vaccination intention using a multilevel analysis.
Methods: This cross-sectional study analyzed raw data from the 2021 Korea Community Health Survey and regional statistics from 255 health centers, with a final sample of 229,216 individuals. Multilevel analysis was conducted, focusing on individual, household, and community-level factors. Individual-level factors included demographics, health status, and COVID-19 concerns; household-level factors included income and marital status; and community-level factors included city type and vaccination rates.
Results: At the individual level, significant differences were observed across all variables. At the household level, higher vaccination intention was associated with households of 4 or more members and a monthly income of 4 million Korean won or more. At the community level, higher flu vaccination rates, greater concern about COVID-19 infection, and higher COVID-19 vaccination rates were linked to increased vaccination intention.
Conclusion: This study highlights that COVID-19 vaccination intention is influenced by factors at the individual, household, and community levels. Vaccination strategies that integrate household and community-level approaches may be more effective. Policymakers should consider both individual and social health factors when designing vaccination policies.
{"title":"Multilevel analysis of individual, household, and community factors influencing COVID-19 vaccination intention: evidence from the 2021 Korea Community Health Survey.","authors":"Ji-Seon Seong, Jong-Yeon Kim","doi":"10.24171/j.phrp.2024.0254","DOIUrl":"10.24171/j.phrp.2024.0254","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate the combined effects of individual, household, and community-level factors on coronavirus disease 2019 (COVID-19) vaccination intention using a multilevel analysis.</p><p><strong>Methods: </strong>This cross-sectional study analyzed raw data from the 2021 Korea Community Health Survey and regional statistics from 255 health centers, with a final sample of 229,216 individuals. Multilevel analysis was conducted, focusing on individual, household, and community-level factors. Individual-level factors included demographics, health status, and COVID-19 concerns; household-level factors included income and marital status; and community-level factors included city type and vaccination rates.</p><p><strong>Results: </strong>At the individual level, significant differences were observed across all variables. At the household level, higher vaccination intention was associated with households of 4 or more members and a monthly income of 4 million Korean won or more. At the community level, higher flu vaccination rates, greater concern about COVID-19 infection, and higher COVID-19 vaccination rates were linked to increased vaccination intention.</p><p><strong>Conclusion: </strong>This study highlights that COVID-19 vaccination intention is influenced by factors at the individual, household, and community levels. Vaccination strategies that integrate household and community-level approaches may be more effective. Policymakers should consider both individual and social health factors when designing vaccination policies.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"169-180"},"PeriodicalIF":2.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12066228/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143469515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-04-22DOI: 10.24171/j.phrp.2024.0335
Yun Gyeong Lee, Mi-Sook Kwak, Jeong Eun Kim, Min Sun Kim, Dong Un No, Hee Youl Chai
Synthetic data, generated using advanced artificial intelligence (AI) techniques, replicates the statistical properties of real-world datasets while excluding identifiable information. Although synthetic data does not consist of actual data points, it is derived from original datasets, thereby enabling analyses that yield results comparable to those obtained with real data. Synthetic datasets are evaluated based on their utility-a measure of how effectively they mirror real data for analytical purposes. This paper presents the generation of synthetic datasets through the Healthcare Big Data Showcase Project (2019-2023). The original dataset comprises comprehensive multi-omics data from 400 individuals, including cancer survivors, chronic disease patients, and healthy participants. Synthetic data facilitates efficient access and robust analyses, serving as a practical tool for research and education. It addresses privacy concerns, supports AI research, and provides a foundation for innovative applications across diverse fields, such as public health and precision medicine.
{"title":"Synthetic data production for biomedical research.","authors":"Yun Gyeong Lee, Mi-Sook Kwak, Jeong Eun Kim, Min Sun Kim, Dong Un No, Hee Youl Chai","doi":"10.24171/j.phrp.2024.0335","DOIUrl":"https://doi.org/10.24171/j.phrp.2024.0335","url":null,"abstract":"<p><p>Synthetic data, generated using advanced artificial intelligence (AI) techniques, replicates the statistical properties of real-world datasets while excluding identifiable information. Although synthetic data does not consist of actual data points, it is derived from original datasets, thereby enabling analyses that yield results comparable to those obtained with real data. Synthetic datasets are evaluated based on their utility-a measure of how effectively they mirror real data for analytical purposes. This paper presents the generation of synthetic datasets through the Healthcare Big Data Showcase Project (2019-2023). The original dataset comprises comprehensive multi-omics data from 400 individuals, including cancer survivors, chronic disease patients, and healthy participants. Synthetic data facilitates efficient access and robust analyses, serving as a practical tool for research and education. It addresses privacy concerns, supports AI research, and provides a foundation for innovative applications across diverse fields, such as public health and precision medicine.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"16 2","pages":"94-99"},"PeriodicalIF":2.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12066231/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144053005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2024-12-12DOI: 10.24171/j.phrp.2024.0222
Syed Ishtiaque Hossain, Rapty Sarker, Sardar Mohammad Ashraful Islam, Mohiuddin Ahmed Bhuiyan, Mma Shalahuddin Qusar, Md Rabiul Islam
Background: Obsessive-compulsive disorder (OCD) is a prevalent mental health condition that impacts daily life. It is thought to be associated with genetic, biological, and structural brain changes, serotonergic abnormalities, altered neuromodulation, and environmental factors. Limited observational studies have examined cytokines in Bangladeshi patients with OCD. This study aimed to assess the levels of eotaxin-1 and interleukin (IL)-34 in individuals with this disorder.
Methods: This case-control observational study included 58 patients with OCD and 30 healthy controls (HCs) matched for age, sex, and body mass index. The severity of OCD was assessed using the Yale-Brown obsessive-compulsive scale (Y-BOCS). Psychiatrists evaluated participants according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Serum levels of eotaxin-1 and IL-34 were measured using enzyme-linked immunosorbent assay kits.
Results: Patients with OCD exhibited significantly higher serum eotaxin-1 levels (121.13±7.84 pg/mL) than HCs (85.52±9.42 pg/mL). Conversely, IL-34 levels were considerably lower in patients than in HCs (119.02±14.53 pg/mL vs. 179.96±27.88 pg/mL). The Cohen d values for eotaxin-1 and IL-34 were 0.55 and -0.48, respectively. Among patients with OCD, a significant positive correlation was found between serum eotaxin-1 level and Y-BOCS score, along with a negative correlation between serum eotaxin-1 and IL-34 levels.
Conclusion: The findings suggest that altered eotaxin-1 and IL-34 levels may be associated with OCD. These chemokines and cytokines could serve as primary tools for assessing the risk of OCD, warranting further clinical investigation. This could potentially support more extensive research and the development of diagnostic and therapeutic strategies targeting these pathways.
目的:强迫症(OCD)是一种影响日常生活的普遍心理健康状况。它被认为与遗传、生物和大脑结构改变、血清素能异常、神经调节改变和环境因素有关。有限的观察性研究检查了孟加拉国强迫症患者的细胞因子。本研究旨在评估这种疾病患者中eotaxin-1和白细胞介素(IL)-34的水平。方法:本病例对照观察性研究纳入58例强迫症患者和30例年龄、性别和体重指数相匹配的健康对照(hc)。强迫症的严重程度采用耶鲁-布朗强迫症量表(Y-BOCS)进行评估。精神科医生根据《精神疾病诊断与统计手册》第五版对参与者进行评估。采用酶联免疫吸附测定试剂盒检测血清eotaxin-1和IL-34水平。结果:OCD患者血清eotaxin-1水平(121.13±7.84 pg/mL)明显高于正常人(85.52±9.42 pg/mL)。相反,患者的IL-34水平明显低于hc(119.02±14.53 pg/mL vs. 179.96±27.88 pg/mL)。eotaxin-1和IL-34的Cohen d值分别为0.55和-0.48。OCD患者血清eotaxin-1水平与Y-BOCS评分呈显著正相关,血清eotaxin-1水平与IL-34呈显著负相关。结论:eotaxin-1和IL-34水平的改变可能与强迫症有关。这些趋化因子和细胞因子可以作为评估强迫症风险的主要工具,值得进一步的临床研究。这可能会支持更广泛的研究和针对这些途径的诊断和治疗策略的发展。
{"title":"Altered eotaxin-1 and interleukin-34 levels in obsessive-compulsive disorder: a case-control observational study in Bangladesh.","authors":"Syed Ishtiaque Hossain, Rapty Sarker, Sardar Mohammad Ashraful Islam, Mohiuddin Ahmed Bhuiyan, Mma Shalahuddin Qusar, Md Rabiul Islam","doi":"10.24171/j.phrp.2024.0222","DOIUrl":"10.24171/j.phrp.2024.0222","url":null,"abstract":"<p><strong>Background: </strong>Obsessive-compulsive disorder (OCD) is a prevalent mental health condition that impacts daily life. It is thought to be associated with genetic, biological, and structural brain changes, serotonergic abnormalities, altered neuromodulation, and environmental factors. Limited observational studies have examined cytokines in Bangladeshi patients with OCD. This study aimed to assess the levels of eotaxin-1 and interleukin (IL)-34 in individuals with this disorder.</p><p><strong>Methods: </strong>This case-control observational study included 58 patients with OCD and 30 healthy controls (HCs) matched for age, sex, and body mass index. The severity of OCD was assessed using the Yale-Brown obsessive-compulsive scale (Y-BOCS). Psychiatrists evaluated participants according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Serum levels of eotaxin-1 and IL-34 were measured using enzyme-linked immunosorbent assay kits.</p><p><strong>Results: </strong>Patients with OCD exhibited significantly higher serum eotaxin-1 levels (121.13±7.84 pg/mL) than HCs (85.52±9.42 pg/mL). Conversely, IL-34 levels were considerably lower in patients than in HCs (119.02±14.53 pg/mL vs. 179.96±27.88 pg/mL). The Cohen d values for eotaxin-1 and IL-34 were 0.55 and -0.48, respectively. Among patients with OCD, a significant positive correlation was found between serum eotaxin-1 level and Y-BOCS score, along with a negative correlation between serum eotaxin-1 and IL-34 levels.</p><p><strong>Conclusion: </strong>The findings suggest that altered eotaxin-1 and IL-34 levels may be associated with OCD. These chemokines and cytokines could serve as primary tools for assessing the risk of OCD, warranting further clinical investigation. This could potentially support more extensive research and the development of diagnostic and therapeutic strategies targeting these pathways.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"72-80"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2025-02-27DOI: 10.24171/j.phrp.2025.0057
Jong-Koo Lee
{"title":"It is time to hold discussions with policymakers.","authors":"Jong-Koo Lee","doi":"10.24171/j.phrp.2025.0057","DOIUrl":"10.24171/j.phrp.2025.0057","url":null,"abstract":"","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"16 1","pages":"1-2"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2025-02-17DOI: 10.24171/j.phrp.2025.0004
Anna Vittoria Mattioli
{"title":"Polycystic ovary syndrome, cardiovascular risk, and coffee: a complex interplay.","authors":"Anna Vittoria Mattioli","doi":"10.24171/j.phrp.2025.0004","DOIUrl":"10.24171/j.phrp.2025.0004","url":null,"abstract":"","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"89-90"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2025-02-07DOI: 10.24171/j.phrp.2024.0295
Se-Jin Jeong, Shin Young Park, Boyeong Ryu, Misuk An, Jin-Hwan Jeon, So Young Choi, Seong-Sun Kim
Background: We analyzed the demographic and clinical characteristics of patients diagnosed with coronavirus disease 2019 (COVID-19), focusing specifically on severe/critical cases, and assessed the trends and rates of severity and fatality among these patients in the Republic of Korea.
Methods: Clinical data on patients with COVID-19 from January 20, 2020 to August 30, 2023 were collected from the Korea Disease Control and Prevention Agency's database. We identified patients who progressed to severe/critical conditions and analyzed their demographic and clinical profiles. Severity and fatality rates were calculated and compared annually to track the disease progression over time.
Results: During the surveillance period, 34,572,554 COVID-19 cases were confirmed, among whom 38,112 (0.11%) progressed to severe/critical conditions. Most severe/critical cases occurred in individuals aged ≥60 years, with a notable increase in patients aged ≥80 years from 2022. The overall severity rate was 0.19%, with a fatality rate of 0.10%. However, the severity of cases gradually diminished during the study period. In 2022, the severity and fatality rates decreased to 0.14% and 0.09%, respectively. In 2023, while the severity rate remained stable at 0.15%, the fatality rate further decreased to 0.06%. Notably, throughout the study period, individuals aged ≥80 years had a significantly higher severity rate (2.44%), with a fatality rate of 1.75%.
Conclusion: These findings underscore the importance of prioritizing protection and management strategies for older adults and high-risk groups to mitigate the impact of COVID-19. Continued surveillance and analysis are essential to effectively control COVID-19 and minimize its burden on public health.
{"title":"Characteristics and trends of severe/critical COVID-19 cases in the Republic of Korea (January 2020 to August 2023).","authors":"Se-Jin Jeong, Shin Young Park, Boyeong Ryu, Misuk An, Jin-Hwan Jeon, So Young Choi, Seong-Sun Kim","doi":"10.24171/j.phrp.2024.0295","DOIUrl":"10.24171/j.phrp.2024.0295","url":null,"abstract":"<p><strong>Background: </strong>We analyzed the demographic and clinical characteristics of patients diagnosed with coronavirus disease 2019 (COVID-19), focusing specifically on severe/critical cases, and assessed the trends and rates of severity and fatality among these patients in the Republic of Korea.</p><p><strong>Methods: </strong>Clinical data on patients with COVID-19 from January 20, 2020 to August 30, 2023 were collected from the Korea Disease Control and Prevention Agency's database. We identified patients who progressed to severe/critical conditions and analyzed their demographic and clinical profiles. Severity and fatality rates were calculated and compared annually to track the disease progression over time.</p><p><strong>Results: </strong>During the surveillance period, 34,572,554 COVID-19 cases were confirmed, among whom 38,112 (0.11%) progressed to severe/critical conditions. Most severe/critical cases occurred in individuals aged ≥60 years, with a notable increase in patients aged ≥80 years from 2022. The overall severity rate was 0.19%, with a fatality rate of 0.10%. However, the severity of cases gradually diminished during the study period. In 2022, the severity and fatality rates decreased to 0.14% and 0.09%, respectively. In 2023, while the severity rate remained stable at 0.15%, the fatality rate further decreased to 0.06%. Notably, throughout the study period, individuals aged ≥80 years had a significantly higher severity rate (2.44%), with a fatality rate of 1.75%.</p><p><strong>Conclusion: </strong>These findings underscore the importance of prioritizing protection and management strategies for older adults and high-risk groups to mitigate the impact of COVID-19. Continued surveillance and analysis are essential to effectively control COVID-19 and minimize its burden on public health.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"81-88"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143366119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Mild cognitive impairment (MCI) is prevalent among older adults and may progress to dementia. This study evaluated the effectiveness of a game-based brain exercise program in reducing MCI among older adults.
Methods: A quasi-experimental study was conducted with 2 groups of older participants in Pathum Thani Province, Thailand. A total of 96 individuals with Thai mental state examination (TMSE) scores between 12 to 23, indicating MCI but no dementia diagnosis, were recruited. Using multi-stage sampling, participants were divided into an intervention group (n=48) and a control group (n=48). The intervention group participated in a 6-week game-based brain exercise program, while the control group received a self-administered brain exercise manual. Face-to-face interviews assessed outcomes at baseline, post-intervention, and 3-month follow-up. Data were analyzed using descriptive statistics and repeated-measures analysis of variance.
Results: Significant differences were observed in mean TMSE scores and MCI knowledge between the intervention and control groups at the 3-month follow-up (p<0.001). The intervention group showed significant increases in TMSE scores and MCI knowledge post-intervention and at 3-month follow-up (p<0.001).
Conclusion: The findings suggest that a game-based brain exercise program can improve cognitive function in older adults. Healthcare professionals can implement such programs to reduce MCI by addressing planning, management, and related issues in the future.
{"title":"Effectiveness of a brain exercise program using game-based cognitive enhancement to reduce mild cognitive impairment among older adults in Pathum Thani Province, Thailand: a quasi-experimental study.","authors":"Panida Kunrit, Phannathat Tanthanapanyakorn, Nonlapan Khantikulanon, Sootthikarn Mungkhunthod, Chaninan Praserttai, Sasipa Rungrungrueang, Wanwisa Phonmamuang","doi":"10.24171/j.phrp.2024.0267","DOIUrl":"10.24171/j.phrp.2024.0267","url":null,"abstract":"<p><strong>Background: </strong>Mild cognitive impairment (MCI) is prevalent among older adults and may progress to dementia. This study evaluated the effectiveness of a game-based brain exercise program in reducing MCI among older adults.</p><p><strong>Methods: </strong>A quasi-experimental study was conducted with 2 groups of older participants in Pathum Thani Province, Thailand. A total of 96 individuals with Thai mental state examination (TMSE) scores between 12 to 23, indicating MCI but no dementia diagnosis, were recruited. Using multi-stage sampling, participants were divided into an intervention group (n=48) and a control group (n=48). The intervention group participated in a 6-week game-based brain exercise program, while the control group received a self-administered brain exercise manual. Face-to-face interviews assessed outcomes at baseline, post-intervention, and 3-month follow-up. Data were analyzed using descriptive statistics and repeated-measures analysis of variance.</p><p><strong>Results: </strong>Significant differences were observed in mean TMSE scores and MCI knowledge between the intervention and control groups at the 3-month follow-up (p<0.001). The intervention group showed significant increases in TMSE scores and MCI knowledge post-intervention and at 3-month follow-up (p<0.001).</p><p><strong>Conclusion: </strong>The findings suggest that a game-based brain exercise program can improve cognitive function in older adults. Healthcare professionals can implement such programs to reduce MCI by addressing planning, management, and related issues in the future.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"59-71"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01Epub Date: 2025-02-10DOI: 10.24171/j.phrp.2024.0286
Alwin Issac, Kurvatteppa Halemani, Asha Shetty, Latha Thimmappa, V R Vijay, Kiranmayi Koni, Prabhaker Mishra, Vishwas Kapoor
Background: The objective of this review was to analyze quantitative data on autism spectrum disorder (ASD) and to increase the accuracy of estimates of the prevalence of ASD.
Methods: This review, which was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, included studies conducted from January 2008 to June 2024 on children aged 3 to 18 years that used standardized measurement tools and reported cut-off scores for ASD. The prevalence of ASD was the primary outcome analyzed in this review. The PubMed, Clinical Key, Scopus, Embase, CINAHL, and Web of Science databases were reviewed for relevant studies. The review protocol was registered with PROSPERO and followed the Cochrane collaboration guidelines.
Results: A total of 66 studies reported on the prevalence of ASD, screening 21,313,061 children worldwide. Among these, 25 studies were conducted in Europe, 22 in Asia, and 13 in America. Additionally, 3 studies each were reported from Africa and Australia. According to a meta-analysis, 0.77% of children globally are diagnosed with ASD, with boys comprising 1.14% of this group. Notably, Australia showed the highest prevalence rate, with an effect size of 2.18, highlighting it as a critical area for public health focus.
Conclusion: ASD represents a significant global health burden. Early detection, increased awareness among parents, and prompt intervention are crucial for mitigating developmental problems in children later in life. It is essential for health policymakers to acknowledge the prevalence and growing trends of ASD in order to implement effective interventions.
目的:本综述的目的是分析自闭症谱系障碍(ASD)的定量数据,并提高ASD患病率估计的准确性。方法:本综述根据系统评价和荟萃分析声明的首选报告项目进行报道,包括2008年1月至2024年6月对3至18岁儿童进行的研究,这些研究使用标准化测量工具并报告ASD的截止分数。ASD的患病率是本系统综述和荟萃分析的主要结果。对PubMed、Clinical Key、Scopus、Embase、CINAHL和Web of Science数据库进行了相关研究综述。该评价方案已在PROSPERO注册,并遵循Cochrane合作指南。数据手工输入到Excel中,并使用Stata软件进行分析。17.结果:共有66项研究报道了ASD的患病率,全球筛查了21,313,061名儿童。其中欧洲25项,亚洲22项,美洲13项。此外,非洲和澳大利亚各报告了3项研究。根据一项荟萃分析,全球0.77%的儿童被诊断为自闭症谱系障碍,其中男孩占1.14%。值得注意的是,澳大利亚的患病率最高,效应值为2.18,突出表明澳大利亚是公共卫生重点关注的一个关键领域。结论:自闭症谱系障碍是一个重大的全球健康负担。早期发现、提高父母的认识和及时干预对于减轻儿童以后的发育问题至关重要。为了实施有效的干预措施,卫生政策制定者必须认识到自闭症谱系障碍的患病率和增长趋势。
{"title":"The global prevalence of autism spectrum disorder in children: a systematic review and meta-analysis.","authors":"Alwin Issac, Kurvatteppa Halemani, Asha Shetty, Latha Thimmappa, V R Vijay, Kiranmayi Koni, Prabhaker Mishra, Vishwas Kapoor","doi":"10.24171/j.phrp.2024.0286","DOIUrl":"10.24171/j.phrp.2024.0286","url":null,"abstract":"<p><strong>Background: </strong>The objective of this review was to analyze quantitative data on autism spectrum disorder (ASD) and to increase the accuracy of estimates of the prevalence of ASD.</p><p><strong>Methods: </strong>This review, which was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, included studies conducted from January 2008 to June 2024 on children aged 3 to 18 years that used standardized measurement tools and reported cut-off scores for ASD. The prevalence of ASD was the primary outcome analyzed in this review. The PubMed, Clinical Key, Scopus, Embase, CINAHL, and Web of Science databases were reviewed for relevant studies. The review protocol was registered with PROSPERO and followed the Cochrane collaboration guidelines.</p><p><strong>Results: </strong>A total of 66 studies reported on the prevalence of ASD, screening 21,313,061 children worldwide. Among these, 25 studies were conducted in Europe, 22 in Asia, and 13 in America. Additionally, 3 studies each were reported from Africa and Australia. According to a meta-analysis, 0.77% of children globally are diagnosed with ASD, with boys comprising 1.14% of this group. Notably, Australia showed the highest prevalence rate, with an effect size of 2.18, highlighting it as a critical area for public health focus.</p><p><strong>Conclusion: </strong>ASD represents a significant global health burden. Early detection, increased awareness among parents, and prompt intervention are crucial for mitigating developmental problems in children later in life. It is essential for health policymakers to acknowledge the prevalence and growing trends of ASD in order to implement effective interventions.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"3-27"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143400305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}